Thermo Fisher Scientific Inc. (TMO)
Should You Continue to Hold TMO Stock in Your Portfolio?
Investors continue to be optimistic about Thermo Fisher due to its strategic acquisitions and string of product launches.
Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic
Thermo Fisher Scientific is well-positioned for growth due to its consistent revenue streams, strong M&A track record and minimal macroeconomic dependence. Despite a COVID-related revenue surge and subsequent correction, the company's valuation multiples are now reasonable, offering potential for capital appreciation. 2025 growth drivers include improved biotech funding and China's government stimulus.
TMO Stock to Gain From the New Additions to CTS Portfolio of Products
Thermo Fisher launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to enhance cell therapy development and production.
Thermo Fisher: M&A And Innovation To Drive Sales Growth
The reduction in revenues due to the decline in COVID-19-related products and services is expected to diminish or disappear in 2025. Thermo Fisher has been growing by acquiring other companies. This strategy led to the company growing 174% between 2017 and 2024 Q3 TTM. The company is filling more patents. In the first 11 months of 2024, Thermo Fisher had 254 published patents; its maximum number in a year.
End Market Growth, New Acquisitions Drive Thermo Fisher's Shares
A few of its recent strategic acquisitions that are likely to drive future growth for TMO include the $3.1-billion acquisition of Olink Holdings.
Thermo Fisher Scientific Inc. (TMO) Wolfe 2024 Healthcare Conference (Transcript)
Thermo Fisher Scientific Inc. (NYSE:TMO ) Wolfe 2024 Healthcare Results Conference November 19, 2024 8:00 AM ET Company Participants Marc Casper - Chairman, President and Chief Executive Officer Conference Call Participants Doug Schenkel - Wolfe Research Doug Schenkel All right. Good morning, everybody.
Thermo Fisher Scientific: Near The Bottom And Attractively Valued
Thermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, and favorable funding environments. The company's margins should benefit from volume leverage, cost-saving initiatives, M&A synergies, and favorable price/mix as organic growth improves. TMO's valuation is attractive, trading at a discount to historical averages and peers like Danaher, suggesting potential for P/E multiple re-rating.
Why Thermo Fisher (TMO) International Revenue Trends Deserve Your Attention
Explore how Thermo Fisher's (TMO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Tradepulse Power Inflow Alert: Thermo Fisher Scientific Inc. Climbs Over 9 Points On Session After Alert
Thermo Fisher Scientific, Inc. today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their trading decisions.
Thermo Fisher Scientific Inc. (TMO) Q3 2024 Earnings Call Transcript
Thermo Fisher Scientific Inc. (NYSE:TMO ) Q3 2024 Earnings Conference Call October 23, 2024 8:30 AM ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President and Chief Executive Officer Stephen Williamson - Senior Vice President and Chief Financial Officer Conference Call Participants Michael Ryskin - Bank of America Rachel Vatnsdal - JPMorgan Jack Meehan - Nephron Research Doug Schenkel - Wolfe Research Tycho Peterson - Jefferies Matt Sykes - Goldman Sachs Dan Brennan - TD Cowen Operator Good morning, ladies and gentlemen and welcome to the Thermo Fisher Scientific 2024 Third Quarter Conference Call. My name is Ezra and I will be your coordinator today.
Thermo Fisher (TMO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Thermo Fisher (TMO) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Thermo Fisher Q3 Earnings Top Estimates, Revenues Miss, Stock Dips
In the third quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.
